A*STAR Singapore Immunology Network (A*STAR SIgN)
For one and for all
5 Jun 2012The infection of one dengue virus subtype can lead to the production of antibodies that confer protection against other dengue virus subtypes
Lose some, gain some
22 May 2012Calicneurin inhibitors, used clinically as immunosuppressive drugs, are shown to confer a growth advantage to myeloid cells
Guiding the immune response
8 May 2012Uric acid released from dying cells is a key driver of autoimmune diseases
The good, the bad and the ugly
10 Apr 2012The interaction between good and malignant immune cells may promote blood cancer invasiveness and progression
Bringing battlers to the tumor
13 Mar 2012Chemotherapeutic drugs fight melanoma by attracting immune cells into tumors
Surveying survival outcomes in liver cancer
31 Jan 2012A new molecular test for predicting liver cancer survival rates could lead to the development of improved immunotherapies
Patrolling skin for pathogens
17 Jan 2012The inner layer of skin contains a population of immune cells specialized for fighting infection
Cause of dissemination
17 Jan 2012Invading immune cells promote the growth and spread of primary tumors
Monocytes are not all the same
20 Dec 2011Understanding the differences between various monocyte subtypes could aid diagnosis of blood disorders
The twists and turns of tumor treatment
22 Nov 2011A melanoma drug is linked to long-term changes in the tumor environment in a subset of tumors that respond effectively to the drug
Spotting the invaders
8 Nov 2011A vaccine against a devastating form of malaria common in Asia and South America is one step closer thanks to a long-awaited methodological advance
Breaking into liver cancer
25 Oct 2011Chronic hepatitis B virus enhances liver cancer susceptibility by blocking a key DNA repair enzyme